News und Analysen

The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), and opened the door for companies such as

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) have risen more than 2,000% over the past 20 years. Despite a terrific run-up, it's hard to find an investment bank analyst on Wall Street who expects

Between labor-market data and potential interest-rate cuts, Wall Street has a lot on its plate right now. In an environment like this one, it can be helpful to invest in solid, dividend-paying

The stock market trended higher in August. The popular S&P 500 (SNPINDEX: ^GSPC) index gained 1.9% last month. As of September 10, it has seen a total return of 20.6% in 52 weeks.

The top three

Some decisions are tough to make. Others are so easy that they don't require much thought and are practically no-brainers.

Three Motley Fool contributors believe they've identified dividend stocks

Ken Griffin is the founder and CEO of Citadel, a hedge fund established in 1990, whose long-term performance has been excellent. Citadel's track record suggests that Griffin knows a thing or two

If you're a long-term investor, why should you be paying closer attention to pharmaceutical giant Pfizer (NYSE: PFE)? Because of its dividend, of course! Pfizer's dividend yield is hovering around a

A star stock during the pandemic era wasn't shining so brightly on Friday. On a media report that the current presidential administration is preparing to link a set of fatalities to Covid vaccines

AbbVie (NYSE: ABBV) is a drug company, spun off from Abbott Laboratories in 2013, that you might want to consider for your long-term portfolio. One of the biggest green flags for investing in the

UnitedHealth Group (NYSE: UNH) stock is popping on the back of positive developments.

*Stock prices used were the afternoon prices of Sept. 8, 2025. The video was published on Sept. 10, 2025.

Shares of AbbVie (NYSE: ABBV) were jumping 4.2% higher as of 11:37 a.m. ET on Thursday. The nice gain came after the big drugmaker revealed that it had settled litigation with all companies that

Shares of UnitedHealth Group (NYSE: UNH) are rising on Tuesday, up 8.8% as of 2:23 p.m. ET. The jump comes as the S&P 500 and the Nasdaq Composite ticked up slightly.

The struggling healthcare

The old proverb "patience is a virtue" is very true in the world of investing. Investors who aren't scared off by a struggling stock, have the ability to see the company's long-term potential, and

Quick -- what were you doing back in September of 2022? Were you buying $10,000 of stock in Amgen (NASDAQ: AMGN)? If so, you might be wondering what that's worth today. Even if you didn't buy Amgen

For decades, UnitedHealth Group (NYSE: UNH) could do no wrong. The company raised its dividend by an exceptional 7,266% from 2010 to 2025, while shares rose as much as 1,700% during this run.

But

With patent-protected market exclusivity for their products, pharmaceutical companies reliably produce profits that they aren't shy about distributing to shareholders. In an industry already known

Pfizer (NYSE: PFE) is a fairly well-known drugmaker, with a name that even non-healthcare-oriented types would likely know. That's a testament to the company's longevity and its success as a

Investors haven't been kind to Intuitive Surgical (NASDAQ: ISRG) and Regeneron Pharmaceuticals (NASDAQ: REGN) this year. Both healthcare leaders have encountered company-specific issues that have

What's one of the biggest mistakes investors make? Selling stocks too soon. It's smarter to try to adhere to Warren Buffett's favorite holding period of "forever," or at least as close to that goal

Explore the exciting world of UnitedHealth (NYSE: UNH) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

BioNTech (NASDAQ: BNTX), the Germany-based biotech that scored big early in the pandemic era with the Comirnaty vaccine it developed with Pfizer, had some fresh news from the lab to report on

Dividend stocks that offer high yields can be gold mines for your portfolio as they can generate loads of recurring income for you for years. Whether you want to use the money to reinvest in those

There is no sugarcoating it: Vertex Pharmaceuticals (NASDAQ: VRTX) has faced significant issues this year that have sunk its stock price. The company's shares are down 2% year-to-date, while the S&P

Investing on a budget can still be lucrative. And even though the best stocks tend to attract plenty of attention from investors who bid up their share prices, it's possible to find quality

There are a number of reasons to believe that Pfizer (NYSE: PFE) is an attractive dividend stock. The lofty 6.9% dividend yield is the obvious first reason, but the healthcare giant also has a long